Atlas Trials

Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

Clinical trial NCT06849622 · RECRUITING

Trial details

NCT number
NCT06849622
Sponsor
Meyer Children's Hospital IRCCS
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Celiac Disease in ChildrenDiabetes Mellitus, Type IScreening
Start date
2024-11-04
Primary completion
2026-03-30
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.